3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide

C47H45Cl3F3N15O17 — CID 160963055

IUPAC3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide
SMILESNCCOc1nonc1-c1noc(=O)n1-c1ccc(F)c(Cl)c1.O=C(CCCOc1nonc1-c1noc(=O)n1-c1ccc(F)c(Cl)c1)N1C[C@@H](O)[C@@H](O)C1.O=C(NCCOc1nonc1C(Cc1ccc(Cl)c(F)c1)=NO)N1C[C@@H](O)[C@@H](O)C1
InChIInChI=1S/C18H17ClFN5O7.C17H19ClFN5O6.C12H9ClFN5O4/c19-10-6-9(3-4-11(10)20)25-16(22-31-18(25)29)15-17(23-32-21-15)30-5-1-2-14(28)24-7-12(26)13(27)8-24;18-10-2-1-9(5-11(10)19)6-12(21-28)15-16(23-30-22-15)29-4-3-20-17(27)24-7-13(25)14(26)8-24;13-7-5-6(1-2-8(7)14)19-10(17-22-12(19)20)9-11(18-23-16-9)21-4-3-15/h3-4,6,12-13,26-27H,1-2,5,7-8H2;1-2,5,13-14,25-26,28H,3-4,6-8H2,(H,20,27);1-2,5H,3-4,15H2/t12-,13+;13-,14+;
InChIKeySXGGMZNJKZSLFK-PEXYNQKQSA-N
MW1255.32 g/mol
LogP1.81
Rot. Bonds19

About 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide

3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide (PubChem CID 160963055) has the molecular formula C47H45Cl3F3N15O17 and a molecular weight of 1255.32 g/mol. Its IUPAC name is 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide.

Molecular Properties

Compound Name3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide
PubChem CID160963055
Molecular FormulaC47H45Cl3F3N15O17
Molecular Weight1255.32 g/mol
Exact Mass1253.21
IUPAC Name3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide
SMILESNCCOc1nonc1-c1noc(=O)n1-c1ccc(F)c(Cl)c1.O=C(CCCOc1nonc1-c1noc(=O)n1-c1ccc(F)c(Cl)c1)N1C[C@@H](O)[C@@H](O)C1.O=C(NCCOc1nonc1C(Cc1ccc(Cl)c(F)c1)=NO)N1C[C@@H](O)[C@@H](O)C1
InChIInChI=1S/C18H17ClFN5O7.C17H19ClFN5O6.C12H9ClFN5O4/c19-10-6-9(3-4-11(10)20)25-16(22-31-18(25)29)15-17(23-32-21-15)30-5-1-2-14(28)24-7-12(26)13(27)8-24;18-10-2-1-9(5-11(10)19)6-12(21-28)15-16(23-30-22-15)29-4-3-20-17(27)24-7-13(25)14(26)8-24;13-7-5-6(1-2-8(7)14)19-10(17-22-12(19)20)9-11(18-23-16-9)21-4-3-15/h3-4,6,12-13,26-27H,1-2,5,7-8H2;1-2,5,13-14,25-26,28H,3-4,6-8H2,(H,20,27);1-2,5H,3-4,15H2/t12-,13+;13-,14+;
InChIKeySXGGMZNJKZSLFK-PEXYNQKQSA-N
XLogP1.81
TPSA432.69 Ų
H-Bond Donors7
H-Bond Acceptors29
Rotatable Bonds19
Heavy Atoms85
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001255.32
LogP ≤ 51.81
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide?
The IUPAC name of 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide (CID 160963055) is 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide.
What is the SMILES notation for 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide?
The canonical SMILES for 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide is NCCOc1nonc1-c1noc(=O)n1-c1ccc(F)c(Cl)c1.O=C(CCCOc1nonc1-c1noc(=O)n1-c1ccc(F)c(Cl)c1)N1C[C@@H](O)[C@@H](O)C1.O=C(NCCOc1nonc1C(Cc1ccc(Cl)c(F)c1)=NO)N1C[C@@H](O)[C@@H](O)C1.
What is the InChIKey of 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide?
The InChIKey is SXGGMZNJKZSLFK-PEXYNQKQSA-N. The full InChI is InChI=1S/C18H17ClFN5O7.C17H19ClFN5O6.C12H9ClFN5O4/c19-10-6-9(3-4-11(10)20)25-16(22-31-18(25)29)15-17(23-32-21-15)30-5-1-2-14(28)24-7-12(26)13(27)8-24;18-10-2-1-9(5-11(10)19)6-12(21-28)15-16(23-30-22-15)29-4-3-20-17(27)24-7-13(25)14(26)8-24;13-7-5-6(1-2-8(7)14)19-10(17-22-12(19)20)9-11(18-23-16-9)21-4-3-15/h3-4,6,12-13,26-27H,1-2,5,7-8H2;1-2,5,13-14,25-26,28H,3-4,6-8H2,(H,20,27);1-2,5H,3-4,15H2/t12-,13+;13-,14+;.
What are the key properties of 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide?
3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide has a molecular weight of 1255.32 g/mol, XLogP of 1.81, 19 rotatable bonds, 7 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(2-aminoethoxy)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-one;4-(3-chloro-4-fluorophenyl)-3-[4-[4-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-4-oxobutoxy]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one;(3S,4R)-N-[2-[[4-[C-[(4-chloro-3-fluorophenyl)methyl]-N-hydroxycarbonimidoyl]-1,2,5-oxadiazol-3-yl]oxy]ethyl]-3,4-dihydroxypyrrolidine-1-carboxamide is sourced from PubChem (CID 160963055), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).